Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
Objective: to assess the clinical and economic efficiency and impact on the budget when using the drug Mirabegron in the treatment of an overactive bladder. Materials and methods. Study design — retrospective analysis of published data. Pharmacoeconomic analysis methods — cost analysis, clinical and...
Main Authors: | I. N. Dyakov, G. R. Kasyan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2021-04-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/560 |
Similar Items
-
Pharmacoeconomic evaluation of mirabegron: results of the healthcare budget impact analysis
by: A. S. Kolbin, et al.
Published: (2018-06-01) -
Pharmacoeconomic evaluation of ipragliflozin in combination with metformin in comparison with other regimens of therapy for type 2 diabetes mellitus
by: A. S. Kolbin, et al.
Published: (2021-02-01) -
Economic analysis of the effectiveness of complex rehabilitation in children with spastic forms of cerebral palsy with injections of botulinum neurotoxin type A and without it
by: V. A. Zmanovskaya, et al.
Published: (2018-07-01) -
Clinical and economic efficiency of treatment with dapagliflozin of patients with type 2 diabetes mellitus in Russian health care conditions
by: S. K. Zyryanov, et al.
Published: (2020-04-01) -
Osobennosti mocheispuskaniya u ginekologicheskikh bol'nykh
by: Irina Yur'evna Il'ina, et al.
Published: (2013-10-01)